Pioglitazone improves the cardio-ankle vascular index in patients with type 2 diabetes mellitus treated with metformin

References

• Lee WL Cheung AM Cape D Zinman B Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies Diabetes Care 2000 23 962 968 10895847
   PubMed Web of Science ®Google Scholar
• Stratton IM Adler AI Neil HA Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study BMJ 2000 321 405 412 10938048
   PubMed Web of Science ®Google Scholar
• [No authors listed] UK Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 1998 352 837 853 9742976
   PubMed Web of Science ®Google Scholar
• Stettler C Allemann S Jüni P Glycemic control and macro-vascular disease in type 1 and 2 diabetes mellitus: meta-analysis of randomized trials Am Heart J 2006 152 27 38 16824829
   PubMed Web of Science ®Google Scholar
• [No authors listed] UK Prospective Diabetes Study (UKPDS) Group Effect of intensive blood-glucose control with metformin on complication in over weight patients with type 2 diabetes (UKPDS 34) Lancet 1998 352 854 865 9742977
   PubMed Web of Science ®Google Scholar
• Scarpello JH Howlett HC Metformin therapy and clinical uses Diab Vasc Dis Res 2008 5 157 167 18777488
   PubMed Web of Science ®Google Scholar
• Koenig W Karakas M Zierer A Oxidized LDL and the Risk of Coronary Heart Disease: Results from the MONICA/KORA Augsburg Study Clin Chem 2011 57 1196 1200 21697499
   PubMed Web of Science ®Google Scholar
• Weyer C Funahashi T Tanaka S Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia J Clin Endocrinol Metab 2001 86 1930 1935 11344187
   PubMed Web of Science ®Google Scholar
• Saiki A Oyama T Endo K Preheparin serum lipoprotein mass might be a biomarker of metabolic syndrome Diabetes Res Clin Pract 2007 76 93 101 16956692
   PubMed Web of Science ®Google Scholar
• Staels B Fruchart JC Therapeutic roles of peroxisome proliferator-activated receptor aonist Diabetes 2005 54 2460 2470 16046315
   PubMed Web of Science ®Google Scholar
• Shakuto S Oshima K Tsuchiya E Glimepiride exhibits prophylactic effect on atherosclerosis in cholesterol-fed rabbits Atherosclerosis 2005 182 209 217 16159593
   PubMed Web of Science ®Google Scholar
• Subramanian V Golledge J Ijaz T Bruemmer D Daugherty A Pioglitazone-induced reductions in atherosclerosis occur via smooth muscle cell-specific interaction with PPAR{gamma} Circ Res 2010 107 953 958 20798360
   PubMed Web of Science ®Google Scholar
• Shirai K Itoh Y Sasaki H The effect of insulin sensitizer, troglitazone, on lipoprotein lipase mass in preheparin serum Diabetes Res Clin Pract 1999 46 35 41 10580614
   PubMed Web of Science ®Google Scholar
• Kato T Sawai Y Kanayama H Comparative study of low-dose pioglitazone or metformin treatment in Japanese diabetic patients with metabolic syndrome Exp Clin Endocrinol Diabetes 2009 117 593 599 19924605
   PubMed Web of Science ®Google Scholar
• Shirai K Utino J Otsuka K Takata M A novel blood pressure-independent arterial wall stiffness parameter; cardio-ankle vascular index (CAVI) J Atherosclerosis Thromb 2006 13 101 107
   PubMed Web of Science ®Google Scholar
• Takaki A Ogawa H Wakayama T Cardio-ankle vascular index is a new noninvasive parameter of arterial stiffness Circ J 2007 71 1710 1714 17965489
   PubMed Web of Science ®Google Scholar
• Shirai K Song M Suzuki J Contradictory effects of β1- and α1-aderenergic receptor blockers on cardio-ankle vascular stiffness index (CAVI)- CAVI independent of blood pressure J Atheroscler Thromb 2011 18 49 55 21071883
   PubMed Web of Science ®Google Scholar
• Kubozono T Miyata M Ueyama K Clinical significance and reproducibility of new arterial distensibility index Circ J 2007 71 89 94 17186984
   PubMed Web of Science ®Google Scholar
• Nakamura K Tomaru T Yamamura S Miyashita Y Shirai K Noike H Cardio-ankle vascular index is a candidate predictor of coronary atherosclerosis Circ J 2008 72 598 604 18362432
   PubMed Web of Science ®Google Scholar
• Shirai K Nema T Hiroh Y Itoh Y Miyashita Y Watanabe H Clinical efficacy of the direct assay method using polymers for serum high density lipoprotein cholesterols J Clin Lab Anal 1997 11 82 86 9058241
   PubMed Web of Science ®Google Scholar
• Kobayashi J Hashimoto H Fukamachi I Lipoprotein lipase mass and activity in severe hypertriglyceridemia Clin Chim Acta 1993 216 113 123 8222262
   PubMed Web of Science ®Google Scholar
• Ohira M Endo K Oyama T Improvement of postprandial hyperglycemia and arterial stiffness upon switching from premixed human inuslin 30/70 to biphasic insulin aspart 30/70 Metabolism 2011 60 78 85 20667560
   PubMed Web of Science ®Google Scholar
• Kotani K Maekawa M Kanno T Kondo A Toda N Manabe M Distribution of immunoreactive malondialdehyde-modified low-density lipoprotein in human serum Biochim Biophys Acta 1994 1215 121 125 7947993
   PubMed Web of Science ®Google Scholar
• Mead MG Dangerfield WG The investigation of midband lipoproteins using polyacrylamide gel electrophoresis Clin Chim Acta 1974 51 173 182 4133339
   PubMed Web of Science ®Google Scholar
• Miwa K Low density lipoprotein particles are small in patients with coronary vasospasm Int J Cardiol 2003 87 193 201 12559540
   PubMed Web of Science ®Google Scholar
• Mazzone T Meyer PM Feinstein SB Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial JAMA 2006 296 2572 2581 17101640
   PubMed Web of Science ®Google Scholar
• Nissen SE Nicholls SJ Wolski K PERISCOPE investigators Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial JAMA 2008 299 1561 1573 18378631
   PubMed Web of Science ®Google Scholar
• Yoon JH Kim SK Choi HJ Adiponectin provides additional information to conventional cardiovascular risk factors for assessing the risk of atherosclerosis in both genders PLoS One 2013 8 e75535 24116054
   PubMed Web of Science ®Google Scholar
• Reinstadler S Klug G Feistritzer H Relation of plasma adiponectin levels and aortic stiffness after acute ST-segment elevation myocardial infarction Eur Heart J Acute Caridiovasc Care 2014 3 10 17
   Google Scholar
• Austin MA Breslow JA Hennekens CH Buring JE Willett WC Krauss RM Low density lipoprotein subclass pattern and risk of myocardial infarction J Am Med Assoc 1988 260 1917 1921
   PubMed Web of Science ®Google Scholar
• Nagayama D Endo K Ohira M Effects of body weight reduction on carido-ankle vascular index (CAVI) Obes Res Clin Pract 2013 7 e89 e164 24331770
   PubMed Web of Science ®Google Scholar
• Nagayama D Saiki A Endo K Improvement of cardio-ankle vascular index by glimepiride in type 2 diabetic patients Int J Clin Pract 2010 64 1796 1801 20946343
   PubMed Web of Science ®Google Scholar